Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended June 2024 as against Rs 132.25 crore during the previous quarter ended June 2023. Sales rose 6.96% to Rs 814.65 crore in the quarter ended June 2024 as against Rs 761.66 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 814.65 | 761.66 | 7 |
| OPM % | 28.30 | 18.89 | - |
| PBDT | 265.81 | 180.04 | 48 |
| PBT | 249.40 | 163.68 | 52 |
| NP | 182.33 | 132.25 | 38 |